Iron drug runs out

Supplies of a drug for people with an iron deficiency have run out, but more should be available early next year, Pharmac says.

Pharmac chief executive Wayne McNee said iron liquid Fergon elixir was out of stock but the Government drug-buying agency was working with the supplier, Pacific Pharmaceuticals, to make the drug available as soon as possible.

National's health spokeswoman, Dr Lynda Scott, said yesterday that three "essential everyday drugs", including Fergon elixir, had run out because of Pharmac's "sole supply" drugs policy.

The other drugs were a particular strength Ibuprofen (a painkiller and anti-inflammatory) and Augmentin (an antibiotic).

Mr McNee said the lack of Fergon elixir was serious, but Pharmac was not responsible for manufacture and supply. The drug had not been tendered and there was only one manufacturer in New Zealand.

Fully funded Augmentin was now available, although there had been a brief shortage. Alternative strength Ibuprofen was also available.

Pharmac had tendered about 300 products, letting it make savings of $200 million, with which it bought other drugs.

Herald feature: Health